Experience of Anticovid Plasma Procurement in the Sakha Republic (Yakutia)

DOI

10.2991/ahsr.k.220103.017How to use a DOI?

Keywords

anticovid plasma procurement; OVID-19; antibody; Sakha Republic; Yakutia

Abstract

Anticoid plasma transfusion (AP) is considered to be one of the for COVID-19 treatment. The retrospective study included 73 COVID-19 convalescents who donated plasma of the Blood Transfusion Station in the Republic of Sakha (Yakutia) as potential AP donors. Donors who had a history of COVID-19 infection confirmed SARS-CoV-2 RNA in pharyngeal swabs by polymerase chain reaction method, availability of medical documentation, a period from the moment of the disease of at least 14 days were allowed to the plasma procurement procedure. The antibody titer was chosen as a characteristic of the immunological viability of AP. The characteristics of donors (gender, age) were compared with the antibody titer. The effective antibody titer (1: 800 and more) was found in 87.6 % of donors, low titer (1: 200 and 1: 400) – in 12.4 %.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article under the CC BY-NC license.

Download article (PDF)

TY  - CONF
AU  - A.N. Evseev
AU  - A.R. Ermolaev
AU  - N.V. Savvina
AU  - V.V. Gerasimova
PY  - 2022
DA  - 2022/01/17
TI  - Experience of Anticovid Plasma Procurement in the Sakha Republic (Yakutia)
BT  - Proceedings of the Conference on Health and Wellbeing in Modern Society (CHW 2021)
PB  - Atlantis Press
SP  - 80
EP  - 83
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.220103.017
DO  - 10.2991/ahsr.k.220103.017
ID  - Evseev2022
ER  -